AUPQ480399A0 - Unsaturated fatty acids and their uses in therapy - Google Patents

Unsaturated fatty acids and their uses in therapy

Info

Publication number
AUPQ480399A0
AUPQ480399A0 AUPQ4803A AUPQ480399A AUPQ480399A0 AU PQ480399 A0 AUPQ480399 A0 AU PQ480399A0 AU PQ4803 A AUPQ4803 A AU PQ4803A AU PQ480399 A AUPQ480399 A AU PQ480399A AU PQ480399 A0 AUPQ480399 A0 AU PQ480399A0
Authority
AU
Australia
Prior art keywords
therapy
fatty acids
unsaturated fatty
unsaturated
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ4803A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Priority to AUPQ4803A priority Critical patent/AUPQ480399A0/en
Publication of AUPQ480399A0 publication Critical patent/AUPQ480399A0/en
Priority to PCT/AU2000/001598 priority patent/WO2001046115A1/en
Priority to AU2001223324A priority patent/AU2001223324A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C07C57/12—Straight chain carboxylic acids containing eighteen carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/10—Production of fats or fatty oils from raw materials by extracting
    • C11B1/106—Production of fats or fatty oils from raw materials by extracting using ultra-sounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AUPQ4803A 1999-12-22 1999-12-22 Unsaturated fatty acids and their uses in therapy Abandoned AUPQ480399A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPQ4803A AUPQ480399A0 (en) 1999-12-22 1999-12-22 Unsaturated fatty acids and their uses in therapy
PCT/AU2000/001598 WO2001046115A1 (en) 1999-12-22 2000-12-22 Unsaturated fatty acids and their uses in therapy
AU2001223324A AU2001223324A1 (en) 1999-12-22 2000-12-22 Unsaturated fatty acids and their uses in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ4803A AUPQ480399A0 (en) 1999-12-22 1999-12-22 Unsaturated fatty acids and their uses in therapy

Publications (1)

Publication Number Publication Date
AUPQ480399A0 true AUPQ480399A0 (en) 2000-02-03

Family

ID=3818942

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ4803A Abandoned AUPQ480399A0 (en) 1999-12-22 1999-12-22 Unsaturated fatty acids and their uses in therapy

Country Status (2)

Country Link
AU (1) AUPQ480399A0 (en)
WO (1) WO2001046115A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030049258A1 (en) * 2001-09-11 2003-03-13 Martin Ungerer Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
ITMI20012384A1 (en) 2001-11-12 2003-05-12 Quatex Nv USE OF POLYUNSATURATED FATTY ACIDS FOR THE PRIMARY PREVENTION OF MAJOR CARDIOVASCULAR EVENTS
DE102005003624A1 (en) * 2005-01-26 2006-07-27 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Antioxidative active extract, useful to prepare fatty acid composition, which is useful as e.g. an active agent in pharmaceutical composition, a food supplement and/or food ingredient or an animal feed, comprises Crypthecodinium species
FR2902659A1 (en) 2006-06-23 2007-12-28 Pierre Fabre Medicament Sa DHA ESTER AND ITS USE IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
ES2328893B1 (en) * 2008-05-06 2010-09-22 Consejo Superior De Investigaciones Cientificas PROCEDURE FOR THE PREPARATION OF OREGANIC ACID.
EP2350244A1 (en) * 2008-10-14 2011-08-03 Kai Bioenergy Corporation Hydrodynamic extraction of oils from photosynthetic cultures
FR2949063B1 (en) 2009-08-11 2011-09-30 Pf Medicament PHARMACEUTICAL COMPOSITION COMPRISING A DHA ESTER FOR PARENTERAL ADMINISTRATION
WO2013107247A1 (en) * 2012-01-20 2013-07-25 中国科学院大连化学物理研究所 Method for cultivating microalgae and co-producing alkenes
WO2015129190A1 (en) * 2014-02-28 2015-09-03 備前化成株式会社 Method for purifying stearidonic acid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01300897A (en) * 1988-05-27 1989-12-05 Idemitsu Petrochem Co Ltd Production of delta6,9,12,15-octadecatetraenoic acid-containing lipid
JP2658248B2 (en) * 1988-08-30 1997-09-30 日本油脂株式会社 Red tide plankton control agent
JP2944132B2 (en) * 1990-03-23 1999-08-30 サントリー株式会社 Novel polyunsaturated fatty acid and method for producing the fatty acid or lipid containing the same
FR2679109B1 (en) * 1991-07-18 1994-03-11 Institut Recherche Biologique Sa NEW ANTI-AGING NUTRITIONAL OR DIETETIC SUPPLEMENTS BASED ON FATTY POLY-UNSATURATED ACID.
HU221896B1 (en) * 1993-07-02 2003-02-28 Unilever N.V. Flavouring composition with butter aroma and its production and flavoured food with this
JPH089981A (en) * 1994-07-05 1996-01-16 Kansai Electric Power Co Inc:The Production of highly unsaturated higher fatty acid
JP2000014392A (en) * 1998-07-07 2000-01-18 Ikeda Shokken Kk Production of glyceride containing highly unsaturated fatty acid
FR2782638B1 (en) * 1998-08-28 2003-04-11 Shiseido Internat France S A S COSMETIC USE OF FATTY ACIDS
US6316645B1 (en) * 1998-10-20 2001-11-13 Wisconsin Alumni Research Foundation Synthesis of conjugated polyunsaturated fatty acids
CA2251265A1 (en) * 1998-10-21 2000-04-21 Universite De Sherbrooke Process for lipid extraction of aquatic animal tissues producing a dehydrated residue

Also Published As

Publication number Publication date
WO2001046115A1 (en) 2001-06-28

Similar Documents

Publication Publication Date Title
IL131744A0 (en) Unsaturated oxyalkylene esters and uses thereof
GB0016452D0 (en) Vitamin K and essential fatty acids
AU2738497A (en) Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder
AU9164298A (en) Use of organic acid esters in food products
AU7442398A (en) Glucosamine fatty acid compositions and their use
PL338357A1 (en) Some 5-alkyl-2-arylaminophenyloacetic acids and their derivatives
AU4564399A (en) Polyunsaturated fatty acids in plants
AU6724598A (en) 5-oxysubstituted chinolines and their use as cholesterol ester transfer proteinsinhibitors
IL122405A0 (en) Controlling highly unsaturated fatty acid content in various tissues
AU2003217759A1 (en) Omega-3 fatty acids or omega-3 phosphatidylcholine in the treatment of depression
AU715620C (en) Therapeutic methods and uses
AU1164601A (en) Therapeutic use and formulation
AU3116599A (en) Di-behenyl fumarate and its use in dermatological products
AU5319499A (en) Fatty acids to minimize cancer therapy side effects
AU5240700A (en) Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
AUPQ480399A0 (en) Unsaturated fatty acids and their uses in therapy
AU5836498A (en) N-acyl-hydroxyamino acid esters and their use
AU2418499A (en) Org-5222 in the treatment of depression
AU2634101A (en) Therapeutic preparations of highly unsaturated fatty acids
HK1040486A1 (en) Fatty acid-anticancer conjugates and uses thereof
AU2530199A (en) Targeting immunoreagents useful in therapeutic and diagnostic compositions and methods
IL131666A0 (en) Novel carboxylic acid derivatives their preparation and use in treating cancer
AU5474599A (en) Conjugated linoleic acid alkyl esters in feedstuffs and food
AU2001223324A1 (en) Unsaturated fatty acids and their uses in therapy
AU2001287269A1 (en) Human genes and expression products

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 2332401

Country of ref document: AU